help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on April 24, 2003, doi:10.1164/rccm.200301-103OC

Am. J. Respir. Crit. Care Med., Volume 168, Number 2, July 2003, 222-227

A more recent version of this article appeared on July 15, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200301-103OCv1
168/2/222    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Betsuyaku, T.
Right arrow Articles by Senior, R. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Betsuyaku, T.
Right arrow Articles by Senior, R. M

Submitted on January 27, 2003
Accepted on December 31, 1969

EMMPRIN is Increased in Smokers' Bronchoalveolar Lavage Fluid

Tomoko Betsuyaku1*, Mishie Tanino1, Katsura Nagai1, Yasuyuki Nasuhara1, Masaharu Nishimura1, and Robert M Senior2

1 First Department of Medicine, Hokkaido University School of Medicine, Sapporo, Japan, 2 Departments of Medicine and Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO, USA

* To whom correspondence should be addressed. E-mail: bytomoko{at}med.hokudai.ac.jp.

Extracellular matrix metalloproteinase inducer (EMMPRIN), also called basigin, is present in the lung during development, but its expression in normal adult lung is minimal. Increases of EMMPRIN have been found in various forms of experimental lung injury. To determine whether EMMPRIN might be involved in alveolar injury/repair associated with smoking, we developed an enzyme-linked immunosorbent assay for EMMPRIN and applied it to bronchoalveolar lavage (BAL) fluids from never-smokers (n=7), former smokers (n=16) and current smokers (n=58). The smoker groups included subjects with emphysema as determined by high-resolution chest computed tomography. EMMPRIN levels were significantly elevated in current and former smokers, 315 ± 20 and 175 ± 15 pg/ml SEM, respectively, compared to 31 ± 7 pg/ml in never-smokers, but the EMMPRIN levels of smokers with emphysema were not different from smokers without emphysema. Immunohistochemistry of smokers'lung tissue showed EMMPRIN in bronchiolar epithelium and alveolar macrophages, but EMMPRIN mRNA in alveolar macrophages was not different between current and never-smokers. Matrix metalloproteinase-1 was also detectable in the BAL fluid from some smokers, but not in never-smokers. These findings indicate that smoking is associated with increased intrapulmonary EMMPRIN. Whether EMMPRIN is involved in smoking-induced lung pathology remains to be determined.


Key words: smoking, emphysema, matrix metalloproteinase, alveolar macrophages




This article has been cited by other articles:


Home page
J. Histochem. Cytochem.Home page
N. Odajima, T. Betsuyaku, Y. Nasuhara, and M. Nishimura
Loss of Caveolin-1 in Bronchiolization in Lung Fibrosis
J. Histochem. Cytochem., September 1, 2007; 55(9): 899 - 909.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
K. J. Greenlee, Z. Werb, and F. Kheradmand
Matrix Metalloproteinases in Lung: Multiple, Multifarious, and Multifaceted
Physiol Rev, January 1, 2007; 87(1): 69 - 98.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
D. Xu and M. E. Hemler
Metabolic Activation-related CD147-CD98 Complex
Mol. Cell. Proteomics, August 1, 2005; 4(8): 1061 - 1071.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
K. Nagai, T. Betsuyaku, Y. Ito, Y. Nasuhara, and M. Nishimura
Decrease of vascular endothelial growth factor in macrophages from long-term smokers
Eur. Respir. J., April 1, 2005; 25(4): 626 - 633.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
H. M. Wu, M. Jin, and C. B. Marsh
Toward functional proteomics of alveolar macrophages
Am J Physiol Lung Cell Mol Physiol, April 1, 2005; 288(4): L585 - L595.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. Fuke, T. Betsuyaku, Y. Nasuhara, T. Morikawa, H. Katoh, and M. Nishimura
Chemokines in Bronchiolar Epithelium in the Development of Chronic Obstructive Pulmonary Disease
Am. J. Respir. Cell Mol. Biol., October 1, 2004; 31(4): 405 - 412.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2003
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 301 - 313.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2003 American Thoracic Society
  New Orleans Int'l Conf